| Rudolph Hamad, CAA | |
|
5959 Monclova Rd, Maumee, OH 43537-1888 | |
| (419) 897-5501 | |
| (419) 897-5502 |
| Full Name | Rudolph Hamad |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 28 Years |
| Location | 5959 Monclova Rd, Maumee, Ohio |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710092259 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | AA000003 (District Of Columbia) | Secondary |
| 367H00000X | Anesthesiologist Assistant | 67.000363 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Promedica Toledo Hospital | Toledo, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| A4 Of Ohio Llc | 3971837188 | 27 |
News Archive
Baylor College of Medicine scientists defined a previously unrecognized genetic cause for two types of birth defects found in newborn boys, described in a report published today in the journal Nature Medicine.
In light of the findings from the Prostate Testing for Cancer and Treatment trial published yesterday in the New England Journal of Medicine, the American Society for Radiation Oncology would like to congratulate the authors and investigators for conceiving and completing a difficult clinical trial to randomize care for 2,664 men who volunteered to be a part of this study.
Autism Speaks, the world's leading autism science and advocacy organization, today announced awards totaling $685,968 funding new research in areas of high priority that will advance understanding and treatment of autism spectrum disorders (ASD).
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company has resubmitted the New Drug Application for Intermezzo (zolpidem tartrate sublingual tablet) to the U.S. Food and Drug Administration.
Around half of patients receive radiotherapy as part of their cancer treatment but the dose is limited by the possibility of causing side effects (toxicity) to the normal tissues and organs that surround the tumour.
› Verified 4 days ago
| Entity Name | A4 Of Ohio Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255996567 PECOS PAC ID: 3971837188 Enrollment ID: O20190621001667 |
News Archive
Baylor College of Medicine scientists defined a previously unrecognized genetic cause for two types of birth defects found in newborn boys, described in a report published today in the journal Nature Medicine.
In light of the findings from the Prostate Testing for Cancer and Treatment trial published yesterday in the New England Journal of Medicine, the American Society for Radiation Oncology would like to congratulate the authors and investigators for conceiving and completing a difficult clinical trial to randomize care for 2,664 men who volunteered to be a part of this study.
Autism Speaks, the world's leading autism science and advocacy organization, today announced awards totaling $685,968 funding new research in areas of high priority that will advance understanding and treatment of autism spectrum disorders (ASD).
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company has resubmitted the New Drug Application for Intermezzo (zolpidem tartrate sublingual tablet) to the U.S. Food and Drug Administration.
Around half of patients receive radiotherapy as part of their cancer treatment but the dose is limited by the possibility of causing side effects (toxicity) to the normal tissues and organs that surround the tumour.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rudolph Hamad, CAA 3513 Spencerville Rd, Lima, OH 45805-3923 Ph: (202) 299-6084 | Rudolph Hamad, CAA 5959 Monclova Rd, Maumee, OH 43537-1888 Ph: (419) 897-5501 |
News Archive
Baylor College of Medicine scientists defined a previously unrecognized genetic cause for two types of birth defects found in newborn boys, described in a report published today in the journal Nature Medicine.
In light of the findings from the Prostate Testing for Cancer and Treatment trial published yesterday in the New England Journal of Medicine, the American Society for Radiation Oncology would like to congratulate the authors and investigators for conceiving and completing a difficult clinical trial to randomize care for 2,664 men who volunteered to be a part of this study.
Autism Speaks, the world's leading autism science and advocacy organization, today announced awards totaling $685,968 funding new research in areas of high priority that will advance understanding and treatment of autism spectrum disorders (ASD).
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company has resubmitted the New Drug Application for Intermezzo (zolpidem tartrate sublingual tablet) to the U.S. Food and Drug Administration.
Around half of patients receive radiotherapy as part of their cancer treatment but the dose is limited by the possibility of causing side effects (toxicity) to the normal tissues and organs that surround the tumour.
› Verified 4 days ago
Patrick Alan Huguelet, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 5959 Monclova Rd, Maumee, OH 43537 Phone: 419-897-5501 |